Add Yahoo as a preferred source to see more of our stories on Google. CMR Surgical is based in Cambridge, United Kingdom. (Courtesy of CMR Surgical) This story was originally published on MedTech Dive ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. (T.

CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...

CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...

CMR Surgical, a British company developing the next-generation surgical robotic system and the Nicholson Center, a center of excellence for training, have launched the first U.S.-based training ...

CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system, priming the company to go ahead with US commercialisation ...